1. Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
- Author
-
Clara Bonanad, Francisca Esteve-Claramunt, Sergio García-Blas, Ana Ayesta, Pablo Díez-Villanueva, Jose-Ángel Pérez-Rivera, José Luis Ferreiro, Joaquim Cánoves, Francisco López-Fornás, Albert Ariza Solé, Sergio Raposerias, David Vivas, Regina Blanco, Daznia Bompart Berroterán, Alberto Cordero, Julio Núñez, Lorenzo Fácila, Iván J. Núñez-Gil, José Luis Górriz, Vicente Bodí, Manuel Martínez-Selles, Juan Miguel Ruiz Nodar, and Francisco Javier Chorro
- Subjects
clopidogrel ,Heart diseases ,Gerontología ,Enfermedad cardiovascular ,General Medicine ,Cardiología ,Clorhidrato de prasugrel ,elderly ,antiplatelet therapy ,Malalties del cor ,acute coronary syndrome ,prasugrel ,ticagrelor ,Anticoagulants (Medicina) ,Síndrome coronario agudo ,Anticoagulants (Medicine) - Abstract
The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also present coronary artery disease (CAD). It is imperative to deepen our knowledge regarding the management of these challenging patients through real-world data and specifically designed geriatric studies to help resolve the questions remaining in their disease management. Instituto de Salud Carlos III / FEDER Founds (JR/21/00041, CIBERCV16/11/00486, PI20/00637) Generalitat Valencia, Conselleria d'Educació (PROMETEO/21/008) 4.242 JCR (2020) Q1, 39/167 Medicine, General & Internal 1.040 SJR (2021) Q1, 438/2489 Medicine (miscellaneous) No data IDR 2020 UEV
- Published
- 2022